The optimal treatment strategy of patients with pulmonary embolism (PE) (especially those with intermediate risk) continues to evolve and remains controversial.
Editors
JACC: Cardiovascular Interventions Editor-in-ChiefDavid J. Moliterno, MD, FACC
JACC: Cardiovascular Interventions CME/MOC EditorMichael C. McDaniel, MD
Authors
Robert S. Zhang, MDSripal Bangalore, MD, MHA
Important Dates
Date of Release: November 13, 2023Term of Approval/Date of CME/MOC Expiration: November 12, 2024